The study Zhang et al. showed elevated levels of CD8 + T lymphocytes in patients with OSA compared to controls16 and that activated CD8 + T lymphocytes can have a killing effect on vascular endothelial cells, thus aiding the progression of secondary atherosclerosis. This evidence concerns the gene CD8A and atherosclerosis.